| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/30/2014 | WO2014017599A1 Novel t cell epitope peptide of japanese cypress pollen allergen |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014017515A1 4-[5-(pyridine-4-yl)-1h-1,2,4-triazole-3-yl]pyridine-2-carbonitrile crystalline polymorph and production method therefor |
| 01/30/2014 | WO2014017491A1 Fusion gene of cep55 gene and ret gene |
| 01/30/2014 | WO2014017474A1 Collagen peptide composition production method, dpp-4 inhibitor, and antihyperglycemic agent |
| 01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017145A1 Composition |
| 01/30/2014 | WO2014017093A1 Benzene ring-fused, nitrogen-containing 5-membered heterocyclic compound or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017087A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017046A1 Prophylactic and/or therapeutic agent for radiation damage |
| 01/30/2014 | WO2014016504A1 System for delivering lectin-based active ingredients |
| 01/30/2014 | WO2014016137A1 Compositions for treatment of cancer-related fatigue |
| 01/30/2014 | US20140031397 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 01/30/2014 | US20140031396 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | CA2876391A1 4-[5-(pyridine-4-yl)-1h-1,2,4-triazole-3-yl]pyridine-2-carbonitrile crystalline polymorph and production method therefor |
| 01/29/2014 | EP2690174A1 Method for producing epithelial stem cells |
| 01/29/2014 | EP2690111A1 Anti-mouse aggrus monoclonal antibody |
| 01/29/2014 | EP1790637B1 Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient |
| 01/29/2014 | EP1196638B1 Use of the krit1 gene in angiogenesis |
| 01/29/2014 | CN103547675A Immunostimulatory oligodeoxynucleotides |
| 01/29/2014 | CN103547284A Immunity inducing agent |
| 01/29/2014 | CN103547278A Immunity induction agent |
| 01/29/2014 | CN103540651A Nanometer gold complex as well as preparation and application thereof |
| 01/29/2014 | CN103540499A Sweet wine with heat-clearing and detoxifying effects, and preparation method thereof |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 01/29/2014 | CN103536793A Composition with functions of clearing away heat and toxic materials and removing fire as well as preparation method thereof |
| 01/29/2014 | CN103536781A Radix ophiopogonis traditional Chinese medicinal preparation |
| 01/29/2014 | CN103536676A Bitter gourd traditional Chinese medicine preparation |
| 01/29/2014 | CN103536666A Atractylodes macrocephala Chinese medicine preparation |
| 01/29/2014 | CN102020588B Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 01/29/2014 | CN101801958B Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2014 | CN101501007B Quinazoline derivative |
| 01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/28/2014 | US8637473 Synthetic membrane anchors |
| 01/28/2014 | US8637463 Peptide inhibiting angiotensin converting enzyme |
| 01/28/2014 | US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/28/2014 | US8637311 Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | CA2736019C Methods and compositions for treating ectoparasite infestation |
| 01/28/2014 | CA2459168C Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/23/2014 | WO2014015276A1 α-AND γ-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 01/23/2014 | WO2014014841A1 Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| 01/23/2014 | WO2014014050A1 1-(cycloalkyl-carbonyl)proline derivative |
| 01/23/2014 | WO2014013928A1 Stabilized solid preparation for internal use |
| 01/23/2014 | WO2014013727A1 Immunemodulating agent |
| 01/23/2014 | WO2014013664A1 Prophylactic/therapeutic agent for influenza virus infection |
| 01/23/2014 | WO2014012360A1 Nitrogenous heterocyclic derivatives and their application in drugs |
| 01/23/2014 | US20140024695 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 01/23/2014 | CA2877232A1 Prophylactic/therapeutic agent for influenza virus infection |
| 01/22/2014 | EP2687532A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 01/22/2014 | EP2687531A1 Tetrahydrocarboline derivative |
| 01/22/2014 | EP2687529A1 Condensed heterocyclic compound |
| 01/22/2014 | EP2687523A1 Novel phenylpyridine derivative and drug containing same |
| 01/22/2014 | EP2687507A1 Nitrogen-containing condensed heterocyclic compound |
| 01/22/2014 | EP2687222A1 Bleomycin hydrolase production promoting agent |
| 01/22/2014 | EP2687203A1 Emulsified composition for dilution and cancer vaccine composition |
| 01/22/2014 | CN103534255A Substituted pyrazolopyrimidines as glucocerebrosidase activators |
| 01/22/2014 | CN103534247A Cyclic sulfonium salt, process for production of same, and alpha-glucosidase inhibitor comprising same |
| 01/22/2014 | CN103533946A Bleomycin hydrolase production promoting agent |
| 01/22/2014 | CN103533936A Liposome containing pyrroloquinoline quinone and sugar |
| 01/22/2014 | CN103533846A Sprouted cereal, method for manufacturing same, food product containing same, and bdnf production accelerator |
| 01/22/2014 | CN103520615A Chinese medicine antisialic powder for treating pediatric salivate |
| 01/22/2014 | CN103520529A Composition for preventing or treating diseases caused by exogenous wind heat and preparation method |
| 01/22/2014 | CN103520347A Summer-heat relieving and throat moistening liquid medicine |
| 01/22/2014 | CN103520248A Maca chewing gum, as well as preparation method and application thereof |
| 01/22/2014 | CN103520162A Application of dabrafenib for programmed necrosis inhibition and liver protection |
| 01/22/2014 | CN103520150A Medical application of vitamin E and vitamin E derivatives serving as G-CSF (granulocyte colony-stimulating factor) secretion inductive agent and cell mobilization agent |
| 01/22/2014 | CN103520044A Maca toothpaste composition, as well as preparation method and application thereof |
| 01/22/2014 | CN101503409B 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments |
| 01/22/2014 | CN101302192B Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
| 01/21/2014 | US8633236 Compounds, compositions and methods |
| 01/21/2014 | US8633221 Method of enhancing lysosomal α-galactosidase A |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8632997 RNA sequence-specific mediators of RNA interference |
| 01/21/2014 | US8632824 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 01/21/2014 | US8632798 Cereal β glucan compositions, methods of preparation and uses thereof |
| 01/21/2014 | CA2427257C Expression vectors able to elicit improved immune response and methods of using same |
| 01/21/2014 | CA2311763C Method for producing human intervertebral disc cells |
| 01/16/2014 | WO2014010748A1 Cyclopropane derivative having bace1 inhibiting activity |
| 01/16/2014 | WO2014010742A1 Pharmaceutical composition or food product composition comprising monogalactosyldiacylglycerol or pharmaceutically acceptable salt thereof as active ingredient |
| 01/16/2014 | WO2014010732A1 Heterocyclic compound |
| 01/16/2014 | WO2014010718A1 Chiral nucleic acid adjuvant |
| 01/16/2014 | WO2014010657A1 Processed nutmeg product and method for producing same |
| 01/16/2014 | WO2014010654A2 Sulfonamide compound combination |
| 01/16/2014 | WO2014010603A1 Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed incontinence, and method for screening compounds to be included in said pharmaceutical composition |
| 01/16/2014 | WO2014010586A1 Pharmaceutical preparation for injection |
| 01/16/2014 | WO2014010281A1 Drug for preventing/treating ocular disease |
| 01/16/2014 | WO2014008629A1 Novel derivatives of donepezil |
| 01/16/2014 | US20140017742 Preparation of microbial oil |
| 01/16/2014 | US20140017314 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 01/15/2014 | EP2684880A1 Dispiropyrrolidine derivative |
| 01/15/2014 | EP2684878A1 Dipyridylamine derivative |
| 01/15/2014 | EP2684861A2 Spiro compounds and pharmaceutical use thereof |
| 01/15/2014 | EP2683733A1 Tfeb variants and uses thereof |
| 01/15/2014 | EP2683370A1 Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| 01/15/2014 | EP1037926B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |